Shawn Griffin, M.D., president and CEO of URAC, shared his insights into best practices for promoting health equity during ...

Mark Cuban Cost Plus Drug Co. has secured another partnership targeting the specialty pharmaceutical market, according to an April 28 news release shared with Becker’s. EverPharm, a specialty ...

A session dives into the trends surrounding specialty drugs and therapies, along with providing an overview of the drug ...

The Indian healthcare industry is witnessing a surge in demand for specialty drugs, including biologics, oncology medications, and rare disease treatments. These medications require specialized ...

In a Q&A with Jeff Casberg, MS, RPh, senior vice president of clinical pharmacy services at IPD Analytics, Casberg explains the evolution of specialty drugs, the future of GLP-1 competition and what ...

In this episode of Healthcare Insider, Cardinal Health’s Mike Brown, vice president of managed services, and Naveen Mansukhani, director of specialty and ambulatory pharmacy solutions ...

BERWYN, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, proudly announces its role as a ...

a global partner delivering customizable solutions to support the specialty pharmaceutical industry, proudly announces its role as a Silver Sponsor at the World Orphan Drug Congress USA (WODC ...

Specialty drug approvals have returned to pre-pandemic levels, with significant developments in gene therapies and treatments for various diseases. A surge of generics, biosimilars, and innovative ...